What is Pacific Biosciences of California Quick Ratio?
Pacific Biosciences of CaliforniaPACB +11.11%53 Quick Ratio is 4.87 as of Mar. 2026, which is 12% above its 10-year median of 4.33. GuruFocus rates PACB with a GF Score™ of 53/100 and a GF Value™ of $1.62 (Fairly Valued). The stock has 7 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Pacific Biosciences of California ranks better than 82.44% on this metric.
PACB'
s Quick Ratio Range Over the Past 10 Years
Min: 1.03 Med: 4.33 Max: 34.97
Current: 4.87
During the past 13 years, Pacific Biosciences of California's highest Quick Ratio was 34.97. The lowest was 1.03. And the median was 4.33.
PACB's Quick Ratio is ranked better than 82.44% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs PACB: 4.87
Pacific Biosciences of California (NAS:PACB) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Pacific Biosciences of California Quick Ratio Related Terms
Pacific Biosciences of California Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacific Biosciences of California Quick Ratio Chart
For the Medical Devices subindustry, Pacific Biosciences of California's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacific Biosciences of California Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Pacific Biosciences of California's Quick Ratio falls into.
Pacific Biosciences of California Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacific Biosciences of California (PACB) has a Quick Ratio of 4.87 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Pacific Biosciences of California and its competitors. This is 12% above median its historical median of 4.33. Over the past decade, Pacific Biosciences of California's Quick Ratio has ranged from 1.03 to 34.97. According to the industry distribution chart, Pacific Biosciences of California ranks #150 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 17.6%.
Is Pacific Biosciences of California's Quick Ratio too high?
Pacific Biosciences of California's current Quick Ratio of 4.87 is 12% above median its 10-year median of 4.33. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 34.97. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Pacific Biosciences of California's value of 4.87 is 161.1% above this industry median. Based on the distribution chart, Pacific Biosciences of California ranks #150 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pacific Biosciences of California has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Quick Ratio compare to CATX and LAB?
According to the Medical Devices & Instruments industry distribution chart, Pacific Biosciences of California ranks #150 out of 854 companies for Quick Ratio. This places Pacific Biosciences of California in the top 18% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.87. Pacific Biosciences of California's value of 4.87 is 161.1% above this benchmark. Historically, Pacific Biosciences of California's own Quick Ratio has ranged from 1.03 to 34.97 over the past decade. While the company's 10-year median is 4.33 vs. the industry median of 1.87, Pacific Biosciences of California has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pacific Biosciences of California's current Quick Ratio of 4.87 is 161.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Pacific Biosciences of California and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pacific Biosciences of California's current Quick Ratio is 4.87, which is 12% above median its own 10-year median of 4.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Based on GuruFocus' analysis, Pacific Biosciences of California (PACB) is currently considered Fairly Valued. The stock's GF Value™ is $1.62, compared to a current price of $1.60 — trading 1.2% below its estimated fair value. The current Quick Ratio is 4.87, which is 12% above median its 10-year median of 4.33 and 161.1% above the Medical Devices & Instruments industry median of 1.87. Pacific Biosciences of California's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Pacific Biosciences of California (PACB), the current Quick Ratio is 4.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pacific Biosciences of California (PACB) Overvalued in 2026?
Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued.
The current stock price of $1.60 is trading 1.2% below its estimated GF Value™ of $1.62.
GuruFocus considers Pacific Biosciences of California to be Fairly Valued.
Key valuation signals for PACB:
Quick Ratio: 4.87 (12% above median its 10-year median of 4.33)
GF Value™: $1.62 vs. price of $1.60 (1.2% below fair value)
Industry Position: 161.1% above the Medical Devices & Instruments median (#150 of 854)
No single metric tells the full story. See the PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pacific Biosciences of California Business Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score
Get the complete analysis for PACB
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACB has been successfully added to your 
